CME - CME Group Inc. | BullzEye View

CME

$243.61 1.49 (-0.61%) Last updated: Jul 15, 2026 04:30

52-Week Range

$243.61

$218.31 $243.61 $329.16

Fundamentals Overview

CME Group Inc. is near the low of its 52-week range with moderate valuation, trading relatively flat today.

Valuation moderate

P/E 20.9 PEG 1.23 P/B 3.29 P/S 13.06

Intrinsic value (DCF)

+83.4% upside vs price

Profitability

Net margin 62.8%

Risk (Beta)

0.28 — lower vol

Earnings & growth

EPS $11.68 Rev +14% Profit -1.2% vs prior qtr

BullzEye Analysis

Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.

Composite Signal

Sell

Buy

Hold — 64% confidence Risk: Lower Volatility — Beta 0.28. Diversify and only invest what you can afford to lose.

Supporting (Buy):

DCF +83.4% upside vs price · Analyst grade: B+ · Sentiment improving (5 upgrades)

Pressures (Sell):

3M vs S&P 500: -28.5% · 3M vs Financial Services sector: -27.7%

Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.

Key Stats

Market Cap

$88.27B

P/E (TTM)

20.86

EPS (TTM)

$11.68

Dividend Yield

4.62%

52-Week Range

$218.31 - $329.16

Volume vs Avg

N/A

Beta

0.28

About

CME Group Inc., through its various subsidiaries, manages international marketplaces for the exchange of futures and options on futures contracts worldwide. Its extensive array of product offerings includes futures and options linked to a broad spectrum of underlying assets, such as interest rates, equity indices, foreign exchange, agricultural commodities, energy, and metals, alongside fixed-income products. The company additionally furnishes essential clearinghouse services, which entail the v...

Sector: Financial Services

Headquarters: US

Employees: 3,875

IPO Date: Dec 2002

Website: www.cmegroup.com

Beta: 0.28 (Less volatile than market)

Ratings & Grades at a Glance

Overall rating: B+. Recent institutional grades: majority upgrades. Current institutional positions: Buy: 5, Equal Weight: 7, Hold: 1, Neutral: 2, Outperform: 3, Overweight: 10, Sector Perform: 1, Underweight: 1.

Financial story & AI narrative

Open this tab to load the financial story.

Valuation & Ratios

Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.

DCF vs price: DCF estimate is $446.80; current price is $243.61. That’s a +83.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.

Metric	Value
Valuation
P/E (TTM)	20.86
DCF value (model)	$446.80 (83.4% upside)
PEG (TTM)	1.23
P/B (TTM)	3.29
P/S (TTM)	13.06
P/FCF (TTM)	20.39
Liquidity & enterprise
Current Ratio (TTM)	1.02
Quick Ratio (TTM)	1.02
Cash Ratio (TTM)	0.01
Profitability
ROE (TTM)	N/A
ROA (TTM)	N/A
Revenue growth (YoY)	N/A
Net margin (TTM)	62.77%
Gross margin (TTM)	86.34%
Operating margin (TTM)	65.57%
Debt to equity (TTM)	N/A

Latest News

News loads when you open this tab.

Price Target, Ratings & Grades

Analyst price targets, consensus, rating snapshot, and institutional grades for CME.

Analyst Sentiment at a Glance

B+ Sentiment Improving

Buy 5Equal Weight 7Hold 1Neutral 2Outperform 3Overweight 10Sector Perform 1Underweight 1

5 upgrades, 1 downgrade

Price Target Consensus

Current $243.61

Median $318.00

Consensus $307.50

Low consensus $260.00

High consensus $324.00

Stock Grades (Institutions)

Institution	Action	Previous Grade	New Grade	Date
Morgan Stanley	maintain	Overweight	Overweight	2026-07-10
Barclays	maintain	Equal Weight	Equal Weight	2026-07-09
UBS	maintain	Neutral	Neutral	2026-07-06
Raymond James	maintain	Outperform	Outperform	2026-07-02
Keefe, Bruyette & Woods	upgrade	Market Perform	Outperform	2026-06-18
Rothschild & Co	upgrade	Neutral	Buy	2026-06-11
Morgan Stanley	maintain	Overweight	Overweight	2026-04-23
Barclays	maintain	Equal Weight	Equal Weight	2026-04-23
Piper Sandler	maintain	Overweight	Overweight	2026-04-15
Barclays	maintain	Equal Weight	Equal Weight	2026-04-13
Morgan Stanley	maintain	Overweight	Overweight	2026-04-10
Barclays	maintain	Equal Weight	Equal Weight	2026-04-08
Argus Research	downgrade	Buy	Hold	2026-03-04
Morgan Stanley	maintain	Overweight	Overweight	2026-02-05
TD Cowen	maintain	Buy	Buy	2026-02-05
RBC Capital	maintain	Sector Perform	Sector Perform	2026-02-05
Barclays	maintain	Equal Weight	Equal Weight	2026-02-05
JP Morgan	maintain	Underweight	Underweight	2026-02-05
Morgan Stanley	maintain	Overweight	Overweight	2026-01-15
TD Cowen	upgrade	Hold	Buy	2026-01-14
Morgan Stanley	maintain	Overweight	Overweight	2025-12-22
Barclays	maintain	Equal Weight	Equal Weight	2025-12-12
Piper Sandler	maintain	Overweight	Overweight	2025-11-13
Morgan Stanley	maintain	Overweight	Overweight	2025-10-23
Deutsche Bank	upgrade	Hold	Buy	2025-10-23
UBS	maintain	Neutral	Neutral	2025-10-23
Raymond James	maintain	Outperform	Outperform	2025-10-13
Barclays	maintain	Equal Weight	Equal Weight	2025-10-08
Morgan Stanley	maintain	Overweight	Overweight	2025-10-01
Citigroup	upgrade	Neutral	Buy	2025-09-25